Site map
- Home
- About Us
- History
- Management Team
- Board of Directors
- Prof Klaus Strein, Basel
- Eduard Enrico Holdener, Chairman, NovImmune, Basel
- Bernard Mach, Founder and Chairman of SAB, NovImmune, Geneva
- Jack Barbut, CEO, NovImmune, Geneva
- Scientific Advisory Board
- Ken Smith, MD, Cambridge Institute for Medical Research, UK
- Bernard Mach, MD, PhD, Chairman of the SAB, NovImmune, Geneva
- Bart N. Lambrecht, MD, PhD, University Hospital Ghent, Ghent
- Paul Peter Tak, MD, PhD, FOCIS Center of Excellence Academic Medical Center, Amsterdam
- Sander van Deventer, MD, PhD, Academic Medical School, Amsterdam
- Hartmut Wekerle, MD, Max Planck Institute, Munich
- Rolf Zinkernagel, MD, University of Zurich
- Investors
- Technology
- Pipeline
- Business Strategy
- Communications
- Press Releases
- GENEVA, Switzerland; December 13th, 2011
- GENEVA, Switzerland; September 22nd, 2011
- GENEVA, Switzerland; May 25th, 2011
- GENEVA, Switzerland; December 17th, 2010
- GENEVA, Switzerland; July 26th, 2010
- GENEVA, Switzerland; October 5th, 2009
- GENEVA, Switzerland; August 25th, 2009
- GENEVA, Switzerland; July 13, 2009
- GENEVA, Switzerland; May 12, 2009
- GENEVA, Switzerland; April 16, 2009
- GENEVA, Switzerland; November 22, 2007
- GENEVA, Switzerland; October 30, 2006
- GENEVA, Switzerland; June 26, 2006
- PRINCETON, N.J.; January 19, 2006
- GENEVA, May 17, 2005
- BASEL and GENEVA, February 20, 2004
- FREMONT (California), TORONTO (Ontario) and GENEVA, November 4, 2003
- SINGAPORE and GENEVA, May 6, 2003
- Company Presentations
- Scientific Publications
- Event Calendar
- Career
|
|
|
